SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer
Clinical trial NCT07109284 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07109284
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-01-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.